Evidence map›Paper›PMID 31732517›Full record

ArticleScience immunology2019

Ketogenic diet activates protective γδ T cell responses against influenza virus infection.

Emily L Goldberg, Ryan D Molony, Eriko Kudo, Sviatoslav Sidorov, Yong Kong, Vishwa Deep Dixit, Akiko Iwasaki

Abstract read
In one paragraph

Article in Science immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. New perspectives: the impact of ketogenic diet on the immune system.Signal transduction and targeted therapy · 2025
    Article
  19. Article
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Emily L GoldbergDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Ryan D MolonyDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA.ORCID 0000-0003-1547-1430
Eriko KudoDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA.
Sviatoslav SidorovDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA.ORCID 0000-0002-1730-265X
Yong KongDepartment of Molecular Biophysics and Biochemistry, W.M. Keck Foundation Biotechnology Resource Laboratory, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-2881-5274
Vishwa Deep DixitDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA. vishwa.dixit@yale.edu akiko.iwasaki@yale.edu.ORCID 0000-0002-5341-6494
Akiko IwasakiDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA. vishwa.dixit@yale.edu akiko.iwasaki@yale.edu.ORCID 0000-0002-7824-9856

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
Molecular and Cellular Transport in MucusR01EB000487 · NIBIB · YALE UNIVERSITY · PI IWASAKI, AKIKO, SALTZMAN, W. MARK · 2002 to 2019
$5.0M
Predoctoral Training Program in VirologyT32AI055403 · NIAID · YALE UNIVERSITY · PI KUMAR, PRITI, MOTHES, WALTHER H · 2003 to 2024
$3.6M
B cell based protection against recurrent herpesR01AI127429 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2021
$2.1M
Thymic adipogenesis and age-related thymic demiseR01AI105097 · NIAID · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2015 to 2018
$1.9M
Restimulating memory T cell responses in elderly by a novel, live influenza vaccineR42AI120269 · NIAID · FLUGEN, INC. · PI BILSEL, PAMUK, IWASAKI, AKIKO · 2017 to 2018
$1.8M
Impact of Ketone Metabolites on Inflammasome Deactivation in GoutR01AR070811 · NIAMS · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2017 to 2021
$1.8M
Innate antiviral defense against Vaginal transmission of ZIKA virusR21AI131284 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2018
$461k
Thymic adipogenesis and age-related thymic demiseR56AI105097 · NIAID · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2013 to 2013
$348k
Impact of ketone bodies on age-related inflammation and healthspan extensionK99AG058801 · NIA · YALE UNIVERSITY · PI GOLDBERG, EMILY LAUREN · 2019 to 2020
$203k
NIAID NIH HHS R01 AI054359NIAID NIH HHS R01 AI105097NIAID NIH HHS R01 AI127429NIAID NIH HHS R21 AI131284NIAID NIH HHS R42 AI120269NIAID NIH HHS R56 AI105097NIAID NIH HHS T32 AI055403NIAMS NIH HHS R01 AR070811NIA NIH HHS K99 AG058801NIA NIH HHS P01 AG051459NIA NIH HHS P30 AG021342NIBIB NIH HHS R01 EB000487
6 · The paper itself

Abstract

Influenza A virus (IAV) infection-associated morbidity and mortality are a key global health care concern, necessitating the identification of new therapies capable of reducing the severity of IAV infections. In this study, we show that the consumption of a low-carbohydrate, high-fat ketogenic diet (KD) protects mice from lethal IAV infection and disease. KD feeding resulted in an expansion of γδ T cells in the lung that improved barrier functions, thereby enhancing antiviral resistance. Expansion of these protective γδ T cells required metabolic adaptation to a ketogenic diet because neither feeding mice a high-fat, high-carbohydrate diet nor providing chemical ketone body substrate that bypasses hepatic ketogenesis protected against infection. Therefore, KD-mediated immune-metabolic integration represents a viable avenue toward preventing or alleviating influenza disease.

Indexed as

Diet, KetogenicAnimalsInfluenza A virusMiceMice, Inbred C57BLMice, KnockoutOrthomyxoviridae InfectionsT-Lymphocytes

Identifiers

PMID31732517
PMCPMC7189564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.